Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Sepsis Diagnostics Market Insights
3.1. Sepsis Diagnostics – Industry snapshot
4. Sepsis Diagnostics - Ecosystem analysis
4.1. Sepsis Diagnostics Market dynamics
4.1.1. Sepsis Diagnostics – Market Forces
4.1.1.1. Sepsis Diagnostics Market driver analysis
4.1.1.2. Sepsis Diagnostics Market restraint/challenges analysis
4.1.1.3. Sepsis Diagnostics Market opportunity analysis
4.1.2. Industry analysis - Porter's five force
4.1.2.1. Bargaining power of supplier
4.1.2.2. Bargaining power of buyer
4.1.2.3. Threat of substitute
4.1.2.4. Threat of new entrant
4.1.2.5. Degree of competition
4.1.3. Sepsis Diagnostics Market PEST analysis, 2017
4.1.4. Sepsis Diagnostics Industry trends
4.1.5. Competitive Ranking Analysis
5. Sepsis Diagnostics Market Size and Forecast by Product
5.1. Key findings
5.2. Instruments
5.2.1. Global market estimates and forecasts, 2017 – 2026
5.3. Blood Culture Media
5.3.1. Global market estimates and forecasts, 2017 – 2026
5.4. Assay Kits and Reagents
5.4.1. Global market estimates and forecasts, 2017 – 2026
6. Sepsis Diagnostics Market Size and Forecast by Technology
6.1. Key findings
6.2. Microbiology
6.2.1. Global market estimates and forecasts, 2017 - 2026
6.3. Molecular Diagnostics
6.3.1. Global market estimates and forecasts, 2017 – 2026
6.4. Immunoassays
6.4.1. Global market estimates and forecasts, 2017 – 2026
6.5. Flow Cytometry
6.5.1. Global market estimates and forecasts, 2017 – 2026
7. Sepsis Diagnostics Market Size and Forecast by Pathogen
7.1. Key findings
7.2. Bacterial Sepsis
7.2.1. Global market estimates and forecasts, 2017 – 2026
7.2.1.1. Gram-Positive Bacteria
7.2.1.2. Gram-Negative Bacteria
7.2.2. Fungal Sepsis
7.2.2.1. Global market estimates and forecasts, 2017 – 2026
8. Sepsis Diagnostics Market Size and Forecast by Testing Type
8.1. Key findings
8.2. Laboratory Testing
8.2.1. Global market estimates and forecasts, 2017 - 2026
8.3. PoC Testing
8.3.1. Global market estimates and forecasts, 2017 – 2026
9. Sepsis Diagnostics Market Size and Forecast by Regions
9.1. Key findings
9.2. North America
9.2.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.2.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.2.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.2.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.2.5. U.S.
9.2.5.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.2.5.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.2.5.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.2.5.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.2.6. Canada
9.2.6.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.2.6.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.2.6.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.2.6.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.3. Europe
9.3.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.3.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.3.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.3.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.3.5. Germany
9.3.5.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.3.5.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.3.5.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.3.5.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.3.6. UK
9.3.6.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.3.6.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.3.6.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.3.6.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.3.7. France
9.3.7.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.3.7.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.3.7.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.3.7.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.3.8. Italy
9.3.8.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.3.8.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.3.8.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.3.8.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.4. Asia Pacific
9.4.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.4.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.4.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.4.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.4.5. China
9.4.5.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.4.5.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.4.5.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.4.5.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.4.6. India
9.4.6.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.4.6.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.4.6.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.4.6.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.4.7. Japan
9.4.7.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.4.7.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.4.7.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.4.7.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.4.8. Australia
9.4.8.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.4.8.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.4.8.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.4.8.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.5. Latin America
9.5.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.5.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.5.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.5.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.5.5. Brazil
9.5.5.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.5.5.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.5.5.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.5.5.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.5.6. Mexico
9.5.6.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.5.6.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.5.6.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.5.6.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
9.6. Middle East & Africa
9.6.1. Sepsis Diagnostics Market by Products, 2017 - 2026
9.6.2. Sepsis Diagnostics Market by Technology, 2017 - 2026
9.6.3. Sepsis Diagnostics Market by Pathogen, 2017 - 2026
9.6.4. Sepsis Diagnostics Market by Testing Type, 2017 - 2026
10. Company Profiles
10.1. Becton, Dickinson and Company
10.1.1. Overview
10.1.2. Financials
10.1.3. Product Benchmarking
10.1.4. Recent Developments
10.2. bioMérieux SA
10.2.1. Overview
10.2.2. Financials
10.2.3. Product Benchmarking
10.2.4. Recent Developments
10.3. Roche Diagnostics
10.3.1. Overview
10.3.2. Financials
10.3.3. Product Benchmarking
10.3.4. Recent Developments
10.4. Beckman Coulter, Inc.
10.4.1. Overview
10.4.2. Financials
10.4.3. Product Benchmarking
10.4.4. Recent Developments
10.5. Thermo Fisher Scientific, Inc.
10.5.1. Overview
10.5.2. Financials
10.5.3. Product Benchmarking
10.5.4. Recent Developments
10.6. Cepheid Inc.
10.6.1. Overview
10.6.2. Financials
10.6.3. Product Benchmarking
10.6.4. Recent Developments
10.7. Bruker Corporation
10.7.1. Overview
10.7.2. Financials
10.7.3. Product Benchmarking
10.8. Nanosphere, Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product Benchmarking
10.8.4. Recent Developments